World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
25020
World Ranking
13274
National Ranking
35

Barry Bresnihan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Barry Bresnihan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 298 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Barry Bresnihan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Barry Bresnihan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Barry Bresnihan was affiliated with University College Dublin in Ireland. The scientist's work was connected to this institution during their academic career.

There are no recent papers, co-authors, or frequent publication venues recorded for Barry Bresnihan. Similarly, there is no detailed information regarding specific book publications, fields of study, subfields, or main topics of work available in the data.

Barry Bresnihan is noted as deceased, and as such, this overview reflects their academic profile based on available historical data.

Best Publications

  • Treatment of rheumatoid arthritis with recombinant human interleukin‐1 receptor antagonist

    Barry Bresnihan;José Maria Alvaro‐Gracia;Mark Cobby;Michael Doherty

  • Synovial tissue inflammation in early and late osteoarthritis

    M J Benito;D J Veale;O FitzGerald;W B van den Berg

  • EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis

    W Zhang;M Doherty;G Peat;S Ma Bierma-Zeinstra

  • A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience

    D Kane;L Stafford;B Bresnihan;O FitzGerald

  • Synovial tissue macrophage populations and articular damage in rheumatoid arthritis

    Diarmuid Mulherin;Oliver Fitzgerald;Barry Bresnihan

  • A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.

    Yebin Jiang;Harry K. Genant;Iain Watt;Mark Cobby

  • Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis

    Jasper J. Haringman;Danielle M. Gerlag;Aeilko H. Zwinderman;Tom J.M. Smeets

  • The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis.

    Paul Peter Tak;Barry Bresnihan

  • Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics and treatments in the QUEST-RA study

    Tuulikki Sokka;Sergio Toloza;Maurizio Cutolo;Hannu Kautiainen

  • Comparison of the accuracy of steroid placement with clinical outcome in patients with shoulder symptoms

    J A Eustace;D P Brophy;R P Gibney;B Bresnihan

  • Asymptomatic synovitis precedes clinically manifest arthritis

    Maarten C. Kraan;Hans Versendaal;Margreet Jonker;Barry Bresnihan

  • Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis.

    John R Kirwan;Patricia Minnock;Ade Adebajo;Barry Bresnihan

  • Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis

    D Foell;D Kane;B Bresnihan;T Vogl

  • CLINICAL IMPROVEMENT AND RADIOLOGICAL DETERIORATION IN RHEUMATOID ARTHRITIS: EVIDENCE THAT THE PATHOGENESIS OF SYNOVIAL INFLAMMATION AND ARTICULAR EROSION MAY DIFFER

    D. Mulherin;O. Fitzgerald;B. Bresnihan

  • Development and Assessment of a Computerized Index of Clinical Disease Activity in Systemic Lupus Erythematosus

    D. P. M. Symmons;J. S. Coppock;P. A. Bacon;B. Bresnihan

  • Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.

    George Nuki;Barry Bresnihan;Moraye B Bear;Dorothy McCabe

  • A randomized controlled trial with an anti-CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis

    Jasper J. Haringman;Danielle M. Gerlag;Tom J. M. Smeets;Dominique Baeten;Dominique Baeten

  • Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis.

    Antonio Manzo;Samantha Paoletti;Maresa Carulli;Mark C Blades

  • Reduced synovial membrane macrophage numbers, elam-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis

    Douglas Veale;Ghada Yanni;Sarah Rogers;Louise Barnes

  • QUEST-RA: Quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries

    Tuulikki Sokka;Hannu Kautiainen;Sergui Toloza;Heidi Mäkinen

Frequent Co-Authors

Oliver FitzGerald
Oliver FitzGerald University College Dublin
Douglas J. Veale
Douglas J. Veale University College Dublin
Conleth Feighery
Conleth Feighery Trinity College Dublin
Ursula Fearon
Ursula Fearon Trinity College Dublin
Paul P. Tak
Paul P. Tak GlaxoSmithKline (United Kingdom)
Dominique Baeten
Dominique Baeten University of Amsterdam
Jean-Michel Dayer
Jean-Michel Dayer University of Geneva
Danielle M. Gerlag
Danielle M. Gerlag UCB Pharma (United Kingdom)
John R. Kirwan
John R. Kirwan University of Bristol
Iain B. McInnes
Iain B. McInnes University of Glasgow

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens the door to numerous related degree and career opportunities in the healthcare field. For those interested in leadership or management roles, healthcare administration degrees provide an excellent foundation in hospital or health system operations. Many universities now offer flexible online options to accommodate busy schedules.

If you're aiming for higher positions, a Master’s in Healthcare Administration is a valuable step. You may want to consider the cheapest online MHA programs to make this pathway more affordable. Beyond management, graduate-level clinical roles like nursing are also growing. Those pursuing advanced practice could benefit from the cheapest online DNP programs, which prepare students for top-level nursing positions through online flexibility.

Pharmacists are another vital part of healthcare teams. If your interests lean toward pharmacy, check out online PharmD programs for accessible and often more affordable training options. Each of these online degree routes expands career choices and serves as a stepping stone to rewarding roles in healthcare.

Best Scientists Citing Barry Bresnihan

Recently Published Articles